Details

Autor(en) / Beteiligte

• Meier, Jason P
• Zhang, Hannah J
• Freifelder, Richard
• Bhuiyan, Mohammed
• Selman, Phillip
• Mendez, Megan
• Kankanamalage, Pavithra H. A
• Brossard, Thomas
• Pusateri, Antonino
• Tsai, Hsiu-Ming
• Leoni, Lara
• Penano, Sagada
• Ghosh, Kaustab
• Broder, Brittany A
• Markiewicz, Erica
• Renne, Amy
• Stadler, Walter
• Weichselbaum, Ralph
• Nolen, Jerry
• Kao, Chien-Min
• Chitneni, Satish K
• Rotsch, David A
• Szmulewitz, Russell Z
• Chen, Chin-Tu

Titel

Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

Ist Teil von

• Molecules (Basel, Switzerland), 2023-08, Vol.28 (16), p.6041

Ort / Verlag

Basel: MDPI AG

Erscheinungsjahr

2023

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• In the field of nuclear medicine, the β+ -emitting 43Sc and β− -emitting 47Sc are promising candidates in cancer diagnosis and targeted radionuclide therapy (TRT) due to their favorable decay schema and shared pharmacokinetics as a true theranostic pair. Additionally, scandium is a group-3 transition metal (like 177Lu) and exhibits affinity for DOTA-based chelators, which have been studied in depth, making the barrier to implementation lower for 43/47Sc than for other proposed true theranostics. Before 43/47Sc can see widespread pre-clinical evaluation, however, an accessible production methodology must be established and each isotope’s radiolabeling and animal imaging capabilities studied with a widely utilized tracer. As such, a simple means of converting an 18 MeV biomedical cyclotron to support solid targets and produce 43Sc via the 42Ca(d,n)43Sc reaction has been devised, exhibiting reasonable yields. The NatTi(γ,p)47Sc reaction is also investigated along with the successful implementation of chemical separation and purification methods for 43/47Sc. The conjugation of 43/47Sc with PSMA-617 at specific activities of up to 8.94 MBq/nmol and the subsequent imaging of LNCaP-ENZaR tumor xenografts in mouse models with both 43/47Sc-PSMA-617 are also presented.